SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Alfredo Addeo

Alfredo Addeo

Geneva University Hospitals (HUG), Geneva

Prof. Alfredo Addeo is a consultant medical oncologist and head of the Lung Cancer Center at Geneva University Hospitals (HUG) in Geneva, Switzerland, with an affiliation to the Translational Research Centre in Oncohaematology at the University of Geneva. His work in non-small cell lung cancer focuses on immune checkpoint inhibitors, predictive and prognostic biomarkers, and oncogenic drivers including EGFR, HER2, and PD-L1. He is an active member of ESMO, the European Thoracic Oncology Platform (ETOP), and the IASLC, and is a frequent speaker at major international oncology congresses.

Connect

Alfredo Addeo

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates